ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 332 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,397,188 | -46.4% | 52,984 | -38.3% | 0.20% | -40.7% |
| Q1 2024 | $2,608,145 | +79.7% | 85,879 | +66.2% | 0.33% | +17.7% |
| Q4 2023 | $1,451,466 | +364.1% | 51,672 | +348.4% | 0.28% | +209.9% |
| Q3 2023 | $312,734 | +73.2% | 11,523 | +96.2% | 0.09% | +62.5% |
| Q2 2023 | $180,567 | -16.5% | 5,874 | -2.2% | 0.06% | -23.3% |
| Q1 2023 | $216,360 | +22.2% | 6,005 | +34.0% | 0.07% | +2.8% |
| Q4 2022 | $177,089 | +8.0% | 4,481 | +9.5% | 0.07% | +2.9% |
| Q3 2022 | $164,000 | – | 4,093 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |